Skip to main content

Table 1 Country-specific model parameters for Malaysia

From: Cost-effectiveness analysis of a universal mass vaccination program with a PHiD-CV 2+1 schedule in Malaysia

Parameter Value in children aged <5 y References Rangea PSA distribution
Birth cohort size (2012) 508,774 [21] Not varied NA
Hospitalized pneumococcal meningitis
 Incidence (per 100,000)b 34.7 [25] ±50% Triangular
 CFR (%)b 12.5–19.2 [26] ±20% Triangular
Hospitalized pneumococcal bacteremia
 Incidence (per 100,000)b 46.3 [25] ±50% Triangular
 CFR (%)b 4.1–4.9 [26] ±20% Triangular
All-cause pneumonia
 GP consultation rate (per 100,000)c 4600–12,517 [25, 26] ±50% Triangular
 Hospitalization rate (per 100,000)c 765.8 [25] ±20% Triangular
 CFR (%)c 0.0–0.4 [26] ±20% Triangular
All-cause AOM
 GP consultation rate (per 100,000)d 11,745–16,412 [27] ±50% Triangular
 Myringotomy procedures (per 100,000)d 10.8–27.2 [26, 27] ±20% Triangular
  1. AOM acute otitis media, CFR case fatality ratio, GP general practitioner, PSA probabilistic sensitivity analysis, NA not applicable
  2. aRanges used in the one-way sensitivity analyses
  3. bAge-specific values are in Additional file 2: Table S1
  4. cAge-specific values are in Additional file 2: Table S2
  5. dAge-specific values are in Additional file 2: Table S3